2011-08-04 Assigned to MUSCULOSKELETAL TRANSPLANT FOUNDATION reassignment
MUSCULOSKELETAL TRANSPLANT FOUNDATION ASSIGNMENT OF ASSIGNORS …

US7413734B2 - Treatment of retinitis pigmentosa with human umbilical cord cells - Google
Patents US7413734B2 - Treatment of retinitis pigmentosa with human umbilical cord cells …

The present invention provides compositions and methods of using embryonic-like stem
cells that originate from a post-partum placenta with conventional cord blood compo sitions …

5,589,376 A 12/1996 Anderson et a1......... 435/240.2 5,670,483 A* 9/1997 zhang et
31'""""""""" 514/14 Cells derivedfromhumanumbilical cords are disclosedalong 5,677,181 A …

A method of manufacturing a tissue matrix for implantation into a patient is disclosed. The
method sets forth collecting embryonic stem cells from a placenta which has been treated to …

Cells derived from postpartum placenta and methods for their isolation are provided by the
invention. The invention further provides cultures and compositions of the placenta-derived …

US7524489B2 - Regeneration and repair of neural tissue using postpartum-derived cells -
Google Patents US7524489B2 - Regeneration and repair of neural tissue using postpartum-derived …

The present invention provides placental stem cells and pla cental stem cell populations,
and methods of culturing, pro liferating and expanding the same. The invention also pro …

5,811,094. A 9/1998 Caplanet al...... 424/93.7 tum tissue-derived cells, are provided by the
invention. The 5,827,735 A 10/1998 Young et al................. 435/325 invention also provides …

The present invention provides a method of extracting and recovering embryonic-like stem
cells, including, but not lim ited to pluripotent or multipotent stem cells, from an exsan …